TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Download Report PDF Instantly
Report overview
The global Pre-Clinical Imaging (In-VIVO) Systems market was valued at US$ 848.2 million in 2022 and is projected to reach US$ 1117.6 million by 2029, at a CAGR of 4.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Pre-clinical (in-vivo) imaging is bridging a gap between the vivo clinical research and vitro exploratory. It is increasingly being deployed across the drug development process, specifically in oncology therapeutic area. The advanced research and development facilities and new product developments of the companies are supporting the growth of pre-clinical imaging (in-vivo) industry. Moreover, integration of pre-clinical MRI systems with other imaging modalities is also expected to propel the growth of the global pre-clinical imaging market in coming years.
This report aims to provide a comprehensive presentation of the global market for Pre-Clinical Imaging (In-VIVO) Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pre-Clinical Imaging (In-VIVO) Systems. This report contains market size and forecasts of Pre-Clinical Imaging (In-VIVO) Systems in global, including the following market information:
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Optical Imaging Systems Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pre-Clinical Imaging (In-VIVO) Systems include Perkinelmer, Mr Solutions, Mediso, Bruker Corporation, Trifoil Imaging, Fujifilm Visualsonics, Biospace Lab, Milabs and Li-Cor Biosciences, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pre-Clinical Imaging (In-VIVO) Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pre-Clinical Imaging (In-VIVO) Systems Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Pre-Clinical Imaging (In-VIVO) Systems Market Segment Percentages, by Type, 2022 (%)
Global Pre-Clinical Imaging (In-VIVO) Systems Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Pre-Clinical Imaging (In-VIVO) Systems Market Segment Percentages, by Application, 2022 (%)
Global Pre-Clinical Imaging (In-VIVO) Systems Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Pre-Clinical Imaging (In-VIVO) Systems Market Segment Percentages, By Region and Country, 2022 (%)
The report also provides analysis of leading market participants including:
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pre-Clinical Imaging (In-VIVO) Systems, market overview.
Chapter 2: Global Pre-Clinical Imaging (In-VIVO) Systems market size in revenue and volume.
Chapter 3: Detailed analysis of Pre-Clinical Imaging (In-VIVO) Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pre-Clinical Imaging (In-VIVO) Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pre-Clinical Imaging (In-VIVO) Systems capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
